Tumor lysis syndrome during treatment with AMN107 (Nilotinib) in a patient with chronic myelogenous leukemia accelerated phase


SÖNMEZ M., OVALI E., OMAY S. B.

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, cilt.33, sa.1, ss.91-92, 2008 (SCI-Expanded) identifier identifier identifier